For most women starting out, yes, because it bypasses the liver and does not carry the clot signal oral estrogen does. For a woman with no cardiovascular risk factors who prefers a tablet, a tablet remains entirely reasonable.
The comparison
Atlanta patient guide: four routes, side by side
Read the patch first: its trade-offs are adhesive and heat rather than clot risk, and that shapes every other comparison in this Atlanta guide. Patches deliver a steady level through the skin twice a week, bypass the liver and carry no demonstrated increase in clot risk. They can irritate the skin and they can come off in heat or water.
Tablets are convenient, cheap as generics, and pass through the liver, which raises clotting factors and can affect thyroid medication requirements. They remain a reasonable choice without cardiovascular risk factors.
Gels and sprays share the patch's transdermal advantage without adhesive, applied daily. They need drying time and care about transfer to others. Vaginal preparations are a different category, treating local symptoms only. More on that in vaginal dryness, hair and skin changes and blood clot and stroke risk go further into it. Transfer is the practical catch with gels, so Atlanta patients with young children or a partner at home need to account for drying time and contact.
